Titlebook: Neuroimmunological Diseases; Susumu Kusunoki Book 2016 Springer Japan 2016 Guillain-Barré Syndrome.Multiple Sclerosis.Neuroimmunology.Neur

只看該作者 · 發(fā)表于 2025-3-27 18:09:46

Multiple Sclerosis: Diagnosis and Treatmentfingolimod and intravenous natalizumab are second line, even though they are more effective, because the long-term safety profiles remain unknown. To achieve disease activity-free status (DAFS), which includes the combination of no clinically apparent relapses, no new MRI activity, and no progressio

只看該作者 · 發(fā)表于 2025-3-28 00:58:39

只看該作者 · 發(fā)表于 2025-3-28 05:07:14

Autoantibodies in Guillain-Barré Syndrome (GBS)tions of antiglycolipid antibodies are regulated by the antibody avidity, which is influenced by (1) the specific distribution of target glycolipids in the PNS, (2) the glycolipid environment surrounding target antigens, (3) the amount of targeted glycolipids in specific regions, (4) the steric micr

只看該作者 · 發(fā)表于 2025-3-28 09:36:17

只看該作者 · 發(fā)表于 2025-3-28 10:33:32

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 20:18
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved